Category: Corona Virus

Page 471«..1020..470471472473..480490..»

Coronavirus in Ohio Thursday update: Over 6,500 new cases, 300 hospitalizations – NBC4 WCMH-TV

October 1, 2021

COLUMBUS (WCMH) The Ohio Department of Health has released the latest number of COVID-19 cases in the state.

As of Thursday, Sept. 30, a total of 1,413,972 (+6,530) cases have been reported since the start of the pandemic, leading to 73,083 (+300) hospitalizations and 9,491 (+38) ICU admissions. A total of 6,308,295 Ohioans 53.97% of the states population has started the vaccination process. Thats an increase of 6,938 from the previous day.

The Department of Health reported 125 new deaths Tuesday, bringing the total to 21,945. The state is updating the number only after death certificates have been processed, usually twice a week.

On Saturday, the Ohio Department of Healthreleased guidance on vaccine booster doses. ODH gave the following recommendations:

Ohio recorded9,019coronavirus cases Sept. 10, the most during the Delta wave. It was the highest one-day total since Jan. 8 (9,535). Just 17 days in the entire pandemic has Ohio seen 9,000 cases, and only 10 days have seen more than 10,000. The states highest one-day total was set on Nov. 23 with 11,885 cases.

Continue reading here:

Coronavirus in Ohio Thursday update: Over 6,500 new cases, 300 hospitalizations - NBC4 WCMH-TV

Scientists at UVA believe they have found the key to creating a universal coronavirus vaccine – Charlottesville Tomorrow

September 29, 2021

Pigs can be infected by SARS-CoV-2, but they are also susceptible to an entirely different kind of coronavirus. That virus, called porcine epidemic diarrhea virus, is a distant cousin of SARS-CoV-2.

To the scientists shock and delight, their fusion peptide vaccine not only protected the pigs against COVID-19, it also protected them against porcine epidemic diarrhea virus.

That would suggest this same COVID-19 vaccine would protect against all variants, Zeichner said. So, thats what were working on now.

Zeichner didnt set out to create a universal vaccine. His initial project was to develop an inexpensive and easily manufactured one for SARS-CoV-2.

The new mRNA technology that was used to create the [Pfizer and Moderna vaccines] is great, but its a really elaborate technology that is ideally suited to the modern world, he said. Its a really involved production process that can only be done in a few places. We wanted something that was inexpensive and could be made in factories that already exist around the world.

Zeichners lab was already working on a technique to rapidly create these types of inexpensive vaccines when the COVID-19 pandemic hit last year.

His technique utilizes killed whole-cell bacteria something humans have used to create vaccines for decades.

Whats different about Zeichners approach is he uses a special kind of e-coli bacteria that has had most of its genes deleted. With so few genes, the bacteria essentially becomes an empty vessel to carry the vaccine.

From there, Zeichner infuses synthesized DNA of the SARS-CoV-2 virus into the e-coli bacteria to create antigens the things that induce an immune response in the body on the bacterias surface.

Almost immediately, Zeichners team ran into a problem. The part of the SARS-CoV-2 virus that scientists are using to create antigens (the infamous spike protein visible on all COVID-19 pictures and drawings) was too big to fit on the e-coli bacteria.

Read the original post:

Scientists at UVA believe they have found the key to creating a universal coronavirus vaccine - Charlottesville Tomorrow

NIAID issues new awards to fund pan-coronavirus vaccines – National Institutes of Health

September 29, 2021

News Release

Tuesday, September 28, 2021

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $36.3 million to three academic institutions to conduct research to develop vaccines to protect against multiple types of coronaviruses and viral variants. The awards are intended to fuel vaccine research for a diverse family of coronaviruses, with a primary focus on potential pandemic-causing coronaviruses, such as SARS-CoV-2.

The available COVID-19 vaccines have proven to be remarkably effective at protecting against severe disease and death, said NIAID Director Anthony S. Fauci, M.D. These new awards are designed to look ahead and prepare for the next generation of coronaviruses with pandemic potential.

The new awards are funded by NIAIDs Division of Microbiology and Infectious Diseases and its Division of Allergy, Immunology, and Transplantation through the Emergency Awards Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects. The notice was issued in November 2020 while many SARS-CoV-2 vaccines were still under development because a critical need remained for prophylactic vaccines offering broad protective immunity against other coronaviruses, such as Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

The awards are designed to fund multidisciplinary teams at each institution to conduct research focused on incorporating understanding of coronavirus virology and immunology, immunogen design, and innovative vaccine and adjuvant platforms and technologies to discover, design, and develop pan-coronavirus vaccine candidates that provide broad protective immunity to multiple coronavirus strains. Specific programs will address coronavirus diversity and infectious potential in humans, include innovative immunogen design and vaccine platforms, and approaches to elicit potent and durable pan-coronavirus immunity, and evaluate vaccine candidates in preclinical models. The awardees are expected to be flexible in the response to emerging knowledge about SARS-CoV-2 immune responses and infection and factor in new information as vaccines candidates are developed. Additional awards are expected to be issued under the NOSI in 2022 to support pan-coronavirus vaccine research at more institutions.

The new awards build on the $1.2 billion investment NIAID has made in coronavirus vaccine research since the COVID-19 pandemic began, including multiple projects in pan-coronavirus vaccine research in the NIAID intramural and extramural programs.

A key goal of the initiative is to develop multivalent vaccine platforms and strategies suitable for use in vulnerable populations and to understand vaccine-induced responses and efficacy related to a persons age or sex.

The following awards have been issued:

University of Wisconsin, MadisonProject Title: PanCorVac (Center for Pan-Coronavirus Vaccine Development)Grant: 1 P01AI165077-01

Brigham and Womens Hospital, Bostonroject Title: Discovering Durable Pan-Coronavirus ImmunityGrant: 1 P01AI165072-01

Duke University, Durham, North CarolinaProject Title: Design and Development of a Pan-Betacoronavirus VaccineGrant: 1 P01AI158571-01A1

More information on these awards is available at reporter.nih.gov.

NIAID conducts and supports research at NIH, throughout the United States, and worldwide to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Originally posted here:

NIAID issues new awards to fund pan-coronavirus vaccines - National Institutes of Health

Another 42 deaths tied to coronavirus | Local News | thesheridanpress.com – The Sheridan Press

September 29, 2021

SHERIDAN The number of Wyoming deaths linked to coronavirus climbed to 996 on Tuesday as the Wyoming Department of Health released new information on 42 deaths, including two Sheridan County residents.

The departments weekly update of deaths tied to coronavirus said the 41 all died in August or September and said most of the victims, 35, had been hospitalized for treatment of coronavirus before their deaths.

Six of the victims, five women and one man, were Laramie County residents, while four others, three men and one woman, were from Fremont County.

Four Natrona County residents, two men and two women, also died in September, as did four Park County residents, three men and one woman, and four Platte County residents, three men and one woman.

Other victims included an Albany County man and woman, two Big Horn County men, three Campbell County men, a Carbon County man and a Converse County woman.

A Crook County mans death was also linked to COVID, as was the death of a Goshen County man, a Niobrara County man, two Sheridan County men, a Sweetwater County man and woman, a Teton County woman and two Uinta County men.

The announcement came as the health department announced the number of active coronavirus cases in Wyoming declined for a second consecutive day Tuesday, falling by 45 from Monday to total 3,662.

Continued here:

Another 42 deaths tied to coronavirus | Local News | thesheridanpress.com - The Sheridan Press

The nation faces two pandemics: COVID-19 and cardiovascular disease – WAVY.com

September 29, 2021

PORTSMOUTH, Va. (WAVY) The coronavirus vaccine has been in circulation since late last year, yet only 60.2% of Virginia is fully vaccinated, according to the Virginia Health Department Sept. 29, 2021 report.

The report also reveals 62.4% of the white population and only 58.8% of the Black population has received at least one vaccine dose.

As the pandemic enters its 19th month, the president of the American Heart Association is joining the chorus of concern regarding vaccine hesitancy.

It [the vaccine] is incredibly effective in preventing severe infection, hospitalization, and death. Its among the safest vaccines weve ever produced and its free, said Dr. Donald M. Lloyd in a Zoom video call from Chicago.

The AHA chief is sounding the alarm as health disparities exposed by the pandemic have left the underserved at high risk for two potentially fatal conditions.

The things that put us at risk for COVID, severe COVID infection, are obesity, hypertension and diabetes. Those are the same risk factors that put us at risk for heart disease and stroke, said Lloyd-Jones.

Research indicates the novel coronavirus often enters the body through the nasal passages but then uses the bloodstreams highways to transport a potentially lethal dose of the pathogen.

A lot of the way the virus gets around the body is traveling through the bloodstream and damaging blood vessels and causing small blood clots, he said.

According to the Centers for Disease Control, minorities in America are more likely to catch the coronavirus and die from COVID-19, the disease caused by the coronavirus.

So what can you do now for a fighting chance? The AHA is prescribing the vaccine and Lifes Simple 7.

A healthy diet, physical activity, healthy weight, not smoking and knowing your cholesterol, your blood pressure and your blood sugar numbers. Thats seven and if you have a problem, just pick one of those and work on it and your heart health will improve, said Lloyd-Jones.

To prepare for the next pandemic, Lloyd-Jones is calling for reinvestment in public health, better cooperation between the 50 states and improved health for the next generation.

We need to get much more serious about launching our children into healthy trajectories, meaning, keeping them from developing weight gain that happens in adolescence and young adults. That drives obesity, hypertension and diabetes, he said.

In efforts to debunk a barrage of vaccine misinformation, the American Heart Association of Hampton Roads is hosting a free online Community Conversation on Wednesday, October 13, 2021, from noon to 1 pm.

Panelists will elaborate on vaccine hesitancy in communities of color, debunk vaccine myths and they will share strategies of best practice to maintain good health and wellness, according to a news release.

For more information contact the AHA of Hampton Roads: 757-628-2605

Get the free WAVY News App, available for download in the App Store and Google Play, to stay up to date with all your local news, weather and sports, live newscasts and other live events.

Excerpt from:

The nation faces two pandemics: COVID-19 and cardiovascular disease - WAVY.com

Tracking COVID-19 variants in Texas: Heres where you can find the breakdown – KXAN.com

September 29, 2021

`;// articleContent = document.querySelector(".article-content");// articleContent.innerHTML = articleContent.innerHTML + formbox;let firstParagraph = document.querySelector("div.article-content > p:nth-child(1)");if (firstParagraph !== null) {firstParagraph.insertAdjacentHTML("afterend", formbox);}function waitForElement(id, callback){var goStahp = setInterval(function(){if(document.getElementById(id)){clearInterval(goStahp);callback();}}, 100);}waitForElement("JotFormIFrame-212304983870155", function(){const expandButton = document.querySelector('h3.expand_box_click_to_open_covid_form');expandButton.addEventListener('click', function() {let box = document.querySelector('.corona_form_expand_box_covid_form');let first = 'opening';let second = 'open';let buttonAction = 'Hide story tip submission form';let deviceAction = "Tap";if (window.innerWidth > 666) {deviceAction = "Click";}// console.log(window.innerWidth);if(box.classList.contains(first)) {[first, second] = [second, first];buttonAction = `${deviceAction} to submit a coronavirus story tip`;}expandButton.innerHTML = buttonAction;box.classList.toggle(first);setTimeout(() => {box.classList.toggle(second);}, 0);});var ifr = document.getElementById("JotFormIFrame-212304983870155");if(window.location.href && window.location.href.indexOf("?") > -1) {var get = window.location.href.substr(window.location.href.indexOf("?") + 1);if(ifr && get.length > 0) {var src = ifr.src;src = src.indexOf("?") > -1 ? src + "&" + get : src + "?" + get;ifr.src = src;}}window.handleIFrameMessage = function(e) {if (typeof e.data === 'object') { return; }var args = e.data.split(":");if (args.length > 2) { iframe = document.getElementById("JotFormIFrame-" + args[(args.length - 1)]); } else { iframe = document.getElementById("JotFormIFrame"); }if (!iframe) { return; }switch (args[0]) {case "scrollIntoView":iframe.scrollIntoView();break;case "setHeight":console.log(`case: setHeight`);iframe.style.height = parseInt(args[1]) + 15 + "px";break;case "collapseErrorPage":console.log(`case: collapseErrorPage`);if (iframe.clientHeight > window.innerHeight) {iframe.style.height = window.innerHeight + "px";}break;case "reloadPage":window.location.reload();break;case "loadScript":var src = args[1];if (args.length > 3) {src = args[1] + ':' + args[2];}var script = document.createElement('script');script.src = src;script.type = 'text/javascript';document.body.appendChild(script);break;case "exitFullscreen":if (window.document.exitFullscreen) window.document.exitFullscreen();else if (window.document.mozCancelFullScreen) window.document.mozCancelFullScreen();else if (window.document.mozCancelFullscreen) window.document.mozCancelFullScreen();else if (window.document.webkitExitFullscreen) window.document.webkitExitFullscreen();else if (window.document.msExitFullscreen) window.document.msExitFullscreen();break;}var isJotForm = (e.origin.indexOf("jotform") > -1) ? true : false;if(isJotForm && "contentWindow" in iframe && "postMessage" in iframe.contentWindow) {var urls = {"docurl":encodeURIComponent(document.URL),"referrer":encodeURIComponent(document.referrer)};iframe.contentWindow.postMessage(JSON.stringify({"type":"urls","value":urls}), "*");}};if (window.addEventListener) {window.addEventListener("message", handleIFrameMessage, false);} else if (window.attachEvent) {window.attachEvent("onmessage", handleIFrameMessage);}});//

Read the rest here:

Tracking COVID-19 variants in Texas: Heres where you can find the breakdown - KXAN.com

MacArthur ‘Genius’ Grant To Virologist Who Early On Raised Coronavirus Alarms : Goats and Soda – NPR

September 29, 2021

Trevor Bedford, a computational virologist, has been named a MacArthur Fellow for his work on SARS-CoV-2. His early reaction: "Scary." Courtesy of John D. and Catherine T. MacArthur Foundation hide caption

Trevor Bedford, a computational virologist, has been named a MacArthur Fellow for his work on SARS-CoV-2. His early reaction: "Scary."

Trevor Bedford is a computational virologist and professor at the Fred Hutchinson Cancer Research Center in Seattle who has devoted his professional life to the pandemic for nearly two years.

On February 29, 2020, he used Twitter to report that the genome of a COVID-19 case reported in Washington state showed the first known community transmission in the U.S. "There are some enormous implications here," he wrote. His prior work to track the evolution and spread of other viruses has been critical in understanding this global pandemic.

For his efforts, Bedford has been named a MacArthur Fellow the so-called "genius grant" that comes with a $625,000 grant paid out over 5 years. This is on the heels of an astounding financial award a 7-year, $9 million grant from the Howard Hughes Medical Institute. Robin Young, a host of NPR's Here and Now, interviewed Bedford to learn his thoughts on the origins, spread and possible future of the pandemic.

This interview has been edited for length and clarity.

So you've had quite a month.

It's been an overwhelming September, trying to feel like I can contribute into the future.

Clearly contributions are needed. Are you feeling pressure now?

Yeah, and it's all wrapped up with the pandemic and feeling like I need to somehow try to fix COVID, and it's impossible to fix it. But that's going to be the mission at least.

One thing that's helped is can I call it "crowd-sourced virus tracking?"

That's pretty close. We had back in 2015 a thing called "Next Flu" to try to look at how flu is circulating and help with influenza vaccine strain selection.

And you used the same type of tracking to look at Ebola, Zika ...

By 2019 we had a pretty good system to take publicly shared viral genome sequence data and very quickly build an evolutionary tree or a family tree and use that tree to understand spatial spread and what's going on ...

The genome is the genetic blueprint?

Mmm hmm.

And then you ...

When the first genomes for the novel coronavirus were shared on January 11 in 2020 we immediately had that built and rebuilt [for] a real-time view of what's circulating and how the pandemic is spreading.

What was your early reaction to this novel coronavirus?

Noticing it was a SARS-like coronavirus which is already scary.

Any other concerns?

[Knowing] how quickly coronaviruses evolve. That the initial infection was only in November 2019 and had very quickly ramped, this let us understand how much human-to-human transmission there was at a time when it's not acknowledged that there was human-to-human transmission.

How did you built the family tree of the virus?

We need people and groups from across the world to share their data. And during the pandemic that's been remarkable. We're looking for particular mutations that are shared among those samples.

What does that tell you along with other data points, like international travelers who've been infected by the novel coronavirus?

We're able to estimate the number of secondary infections that one infection causes. On January 23 [2020] we have a public report, we have an "R nought" of 3. And 3 is a really terrifying R nought.

Define R nought.

It means how many infections on average does one infection cause. Flu has an R nought of 2.

Having an R nought of 3 gives you a lot of exponential growth. That is what led to the pandemic very quickly spreading.

And you felt ...

That week mid-January 2020 was rough. For a while it felt like I had this special knowledge that I was trying to share with public health [like] WHO.CDC and kind of being alone with this knowledge. Eventually things caught up, which almost made it better in this tragic and ridiculous way.

Now your software is being used around the world and helping analyze, for example, the spread of the delta strain.

Right now delta has basically taken over the world in a fashion that I don't think many people would have predicted back in April. And we're watching very closely for the emergence of a sublineage of delta that has additional mutations on top of delta that is going to be the next thing to worry about.

Has your own life changed?

It actually has gotten difficult to remember what it was like before. It's been cycles of overwork and burnout, and then particular things cropping up that require more attention like when the variants first emerged.

Do you have any thoughts about the future of this virus?

If we compare SARS-CoV-2 to influenza virus I think it's a helpful analogy. The evolution of SARS-CoV-2 up to this point has been faster [than the influenza virus]. Having something that's that evolvable suggests that it will be able to keep evolving. We'll have to keep updating vaccines.

And the R nought factor [of] 3, which was terrifying back in January 2020, with delta it's now 5 or 6.

If 3 was "horrifying," what can you say about 5 or 6?

This is why places like Vietnam that were able to control the original form have struggled with delta. Because of this high rate of evolution it suggests that you'd have something that's [going to become] the worst of our seasonal respiratory diseases.

What about this winter?

I expect there to be a winter wave. However, we had a number of infections pulled forward by this delta late summer wave that has created its own immunity. Five percent of the U.S. has perhaps gotten delta at this point. So [winter] actually might not be so bad. But looking forward to 2022, 2023 once this [coronavirus] is endemic that's where my comparison with flu comes it, where it's looking like a severe flu season every winter.

For your own future, what do these prizes mean?

It's the scientific dream of having sustained funding to be directed in whatever fashion you'd want, and that's amazing.

How does that make you feel?

It's really been difficult for me to reconcile that with feeling like [these prizes are] coming out of my work on the pandemic. It's hard to accept things given that it came out of such terrible circumstances.

So you don't want to benefit from the global pain of the pandemic?

Yeah.

See the original post:

MacArthur 'Genius' Grant To Virologist Who Early On Raised Coronavirus Alarms : Goats and Soda - NPR

Akron Children’s Hospital offering drive-thru COVID-19 testing – News 5 Cleveland

September 29, 2021

AKRON, Ohio Akron Childrens Hospital will begin offering drive-thru COVID-19 testing at its Akron campus Wednesday.

The drive-thru testing is available to children whether they are patients or not, with or without symptoms, and young adults up to age 26 who are still in the care of Akron Childrens.

Testing will take place in the circular drive by the hospital's Kay Jewelers Pavilion, located at 177 West Exchange Street.

Testing will be available Monday through Friday, from 4 to 7 p.m. and Saturday and Sunday from 9 a.m. to noon.

Testing results are expected to be available within 48 to 72 hours after testing.

Appointments are required and can be scheduled through MyChart.

Insurance information will be required at the time of scheduled and at testing.

Download the News 5 app for free to easily access local coronavirus coverage, and to receive timely and limited news alerts on major COVID-19 developments. Download now on your Apple device here, and your Android device here.

See complete coverage on our Coronavirus Continuing Coverage page.

Vaccinating Ohio - Find the latest news on the COVID-19 vaccines, Ohio's phased vaccination process, a map of vaccination clinics around the state, and links to sign up for a vaccination appointment through Ohio's online portal.

See data visualizations showing the impact of coronavirus in Ohio, including county-by-county maps, charts showing the spread of the disease, and more.

Rebound Northeast Ohio News 5's initiative to help people through the financial impact of the coronavirus by offering one place to go for information on everything available to help and how to access it. We're providing resources on:

Getting Back to Work - Learn about the latest job openings, how to file for benefits and succeed in the job market.

Making Ends Meet - Find help on topics from rent to food to new belt-tightening techniques.

Managing the Stress - Feeling isolated or frustrated? Learn ways to connect with people virtually, get counseling or manage your stress.

Doing What's Right - Keep track of the way people are spending your tax dollars and treating your community.

We're Open! Northeast Ohio is place created by News 5 to open us up to new ways of thinking, new ways of gathering and new ways of supporting each other.

View a map of COVID-19 testing locations here.

Visit Ohio's Coronavirus website for the latest updates from the Ohio Department of Health.

View a global coronavirus tracker with data from Johns Hopkins University.

Follow this link:

Akron Children's Hospital offering drive-thru COVID-19 testing - News 5 Cleveland

Coronavirus Monday update: 22 more deaths and 2,803 new infections – TwinCities.com-Pioneer Press

September 27, 2021

Minnesota health officials recorded 22 more fatalities Monday and there were 2,803 new infections reported.

The latest deaths range in age from their 30s to their 90s with 18 residing in private homes and four in long-term care. All 22 fatalities occurred in September and the death toll is now 8,098 since the pandemic began.

The 2,803 new cases were the result of about 48,500 for a test-positivity rate of about 5.7 percent, above the 5 percent caution threshold. Rates of new infections and patients needing hospital care continue to climb as the states fourth wave of infections continues.

Minnesota only reports new pandemic data on business days and Mondays numbers are from the previous Friday.

There were 755 patients hospitalized including 212 in critical condition. An estimated 18,500 people with active infections are recovering at home.

Minnesota is nearing 700,000 infections diagnosed since the outbreak began in March 2020. There have been 699,966 cases, so far, and of those, 96 percent have recovered enough they no longer need to be isolated.

Health officials say the best way to avoid a severe infection is to be vaccinated. However, breakthrough infections are on rise, but are rarely severe.

Of the 3.1 million fully vaccinated Minnesotans there have been 28,047 who tested positive, 1,495 who needed hospital care and 160 who have died all fractions of a percentage point.

Minnesota has administered 6.3 million doses of vaccine and 3.3 million residents have gotten at least one shot.

Read more here:

Coronavirus Monday update: 22 more deaths and 2,803 new infections - TwinCities.com-Pioneer Press

Page 471«..1020..470471472473..480490..»